Have a personal or library account? Click to login
Clinical Laboratory Validation Study of a High Sensitivity Troponin I Assay on a POCT (Point of Care Testing) Device Cover

References

  1. WHO. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (Acessed 01 February 2024).
  2. Ministério da Saúde, 2019. MS/SVS/CGIAE – Sistema de Informações sobre Mortalidade – SIM. http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/obt10uf.def (Acessed 01 February 2024).
  3. Salari N, Morddarvanjoghi F, Abdolmaleki A, Rasoulpoor S, Khaleghi AA, Hezarkhani LA, et al. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovascular Disorders. 2023; 23:206. DOI: 10.1186/s12872-023-03231-w
  4. Basit H, Malik A, Huecker MR. Non-ST-segment elevation Myocardial Infarction. StatPearls. 2024. [Accessed online: https://www.ncbi.nlm.nih.gov/books/NBK513228/]
  5. Chapman AR, Lee KK, McAllister DA, Cullne L, Greenslade JH, Parsonage W, et al. Association of high-sensitivity cardiac Troponin I concentration with cardiac outcomes in patients with suspected Acute Coronary Syndrome. JAMA. 2017; 318(19):19131924. DOI: 10.1001/jama.2017.17488
  6. Sandoval Y, Apple FS, Mahler SA, Body R, Collinson PO, Jaffe AS, et al. High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the evaluation and diagnosis of Acute Chest Pain. Circulation. 2022; 146:569581. DOI: 10.1161/CIRCULATIONAHA.122.059678
  7. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal. 2016; 37(3):267315. DOI: 10.1016/j.rec.2015.10.009
  8. van der Linden N, Wildi K, Twerenbold R, Pickering JW, Than M, Cullen L, et al. Combining High-Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction. Circulation. 2018; 138(10):989999. DOI: 10.1161/CIRCULATIONAHA.117.032003
  9. Chaulin A. Current characteristics of methods for determining cardiac troponins and their diagnostic value: A mini-review. Revista de la Facultad de Ciencias Medicas de Cordoba 2021; 78(4):415422. DOI: 10.31053/1853.0605.v78.n4.32988
  10. Kavsak PA, Mondoux SE, Ainsworth C, Worster A. High-sensitivity cardiac troponin and the importance of cutoffs in patients with prior coronary artery bypass grafting with suspected NSTEMI. International Journal of Cardiology. 2022; 356:3637. DOI: 10.1016/j.ijcard.2022.03.041
  11. Romano ER, Liguori ID, Farran JA, do Egito RMP, Romano MLP, Werneck VA, et al. Prognostic score for acute coronary syndrome in a private terciary hospital. Arquivos Brasileiros de Cardiologia. 2014; 102(3):226236. DOI: 10.5935/abc.20140012
  12. Wereski R, Kimenai DM, Taggart C, Doudesis D, Lee KK, Lowry MTH, et al. Cardiac troponin thresholds and kinetics to differentiate myocardial injury and myocardial infarction. Circulation. 2021; 144(7):528538. DOI: 10.1161/CIRCULATIONAHA.121.054302
  13. Krychtiuk KA, Newby LK. High-sensitivity cardiac troponin assays: Ready for prime time! Annual Review of Medicine. 2024; 75:459474. DOI: 10.1146/annurev-med-051022-113931
  14. Bhatnagar D, Kaur I, Kumar A. Ultrasensitive cardiac troponin I antibody based nanohybrid sensor for rapid detection of human heart attack. International Journal of Biological Macromolecules. 2017; 95:505510. DOI: 10.1016/j.ijbiomac.2016.11.037
  15. Periyakaruppan A, Gandhiraman RP, Meyyappan M, Koehne JE. Label-free detection of cardiac troponin-I using carbon nanofiber based nanoelectrode arrays. Anaytical Chemistry. 2013; 85(8):38583863. DOI: 10.1021/ac302801z
  16. Neumann JT, Sörensen NA, Ojeda F, Renné T, Schnabel RB, Zeller T, et al. Early diagnosis of acute myocardial infarction using high-sensitivity troponin I. PLoS One. 2017; 12(3):e0174288. DOI: 10.1371/journal.pone.0174288
  17. Silva PGMBE, Berwanger O, Santos ESD, Sousa ACS, Cavalcante MA, Andrade PB, et al. One year follow-up assessment of patients included in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT). Arq Bras Cardiol. 2020; 114(6):9951003. DOI: 10.36660/abc.20190879
  18. Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Gimenez MR, Badertscher P, et al. How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Clinical Biochemistry. 2018; 53:143155. DOI: 10.1016/j.clinbiochem.2017.12.006
  19. Tang L, Yang J, Wang Y, Deng R. Recent advances in cardiovascular disease biosensors and monitoring technologies. ACS Sensors. 2023; 8(3):956973. DOI: 10.1021/acssensors.2c02311
  20. Collinson P, Aakre KM, Saenger A, Body R, Hammarsten O, Jaffe AS, et al. Cardiac troponin measurement at the point of care: educational recommendations on analytical and clinical aspects by the IFCC Committee on Clinical Applications of Cardiac Bio-Markers (IFCC C-CB). Clinical Chemistry and Laboratory Medicine. 2023; 61(6):989998. DOI: 10.1515/cclm-2022-1270
  21. Ferreira CE, França CN, Correr CJ, Zucker ML, Andriolo A, Scartezini M. Clinical correlations between a ponit-of-care testing system and laboratory automation for lipid profile. Clinica Chimica Acta. 2015; 446:263266. DOI: 10.1016/j.cca.2015.04.036
  22. Cullen L, Collinson PO, Giannitsis E. Point-of-caretesting with high-sensitivity cardiac troponin assays: The challenges and opportunities. Emergency Medicine Journal. 2022; 39:861866. DOI: 10.1136/emermed-2021-211907
  23. Twerenbold R, Neumann JT, Sörensen NA, et al. Prospective validation of the 0/1-h algorithm for early diagnosis of myocardial infarction. Journal of the American College of Cardiology. 2018; 72(6):620632. DOI: 10.1016/j.jacc.2018.05.040
  24. Backus BE, Six AJ, Kelder JC, Bosschaert MA, Mast EG, Mosterd A, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. International Journal of Cardiology. 2013; 168(3):21532158. DOI: 10.1016/j.ijcard.2013.01.255
  25. Aakre KM, Apple FS, Mills NL, Meex SJR, Collinson PO, on behalf of the International Federation of Clinical Chemistry Committee on Clinical Applications of Cardiac Biomarkers (IFCC C-CB). Lower limits for reporting high-sensitivity cardiac troponin assays and impact of analytical performance on patient misclassification. Clinical Biochemistry. 2023; 70(3):497505. DOI: 10.1093/clinchem/hvad185
  26. Xiong-Hang K, Schulz K, Sandoval Y, Smith SW, Saenger AK, Apple FS. Analytical performance comparing siemens whole blood point of care Atellica VTLi to the central laboratory plasma Atellica IM high-sensitivity cardiac troponin I assays. Clinical Biochemistry. 2023; 114:7985. DOI: 10.1016/j.clinbiochem.2023.02.004
  27. Hammarsten O, Becker C, Engberg AE. Methods for analyzing positive cardiac troponin assay interference. Clinical Biochemistry. 2023; 116:2430. DOI: 10.1016/j.clinbiochem.2023.03.004
  28. Denessen EJS, Nass SIJ, Bekers O, VroemeN WHM, Mingels AMA. Circulating forms of cardiac troponin: a review with implications for clinical practice. Journal of Laboratory and Precision Medicine. 2023; 8:111. DOI: 10.21037/jlpm-22-66
  29. Clerico A, Zaninotto M, Passino C, Padoan A, Migliardi M, Plebani M. High-sensitivity methods for cardiac troponins: The mission is not over yet. Advances in Clinical Chemistry. 2021; 103:215252. DOI: 10.1016/bs.acc.2020.08.009
  30. de Barros e Silva PGM, Ferreira AA, Malafaia F, Reis AFMT, Sznejder H, Lopes Junior ACA, et al. Potential performance of a 0 h/1 h algorithm and a single cut-off measure of high-sensitivity troponin T in a diverse population: Main results of the IN-HOPE study. European Heart Journal Acute Cardiovascular Care. 2023; 12(11):755764. DOI: 10.1093/ehjacc/zuad082
  31. Ferreira CES, Guerra JCC, Slhessarenko N, Scartezini M, França CN, Colombini MP, et al. Point-of-care testing: General aspects. Clinical Laboratory. 2018; 64(1):19. DOI: 10.7754/Clin.Lab.2017.170730
  32. Cullen L, Greenslade J, Parsonage W, Stephensen L, Smith SW, Sandoval Y, et al. Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h. European Heart Journal 2024; 00:18. DOI: 10.1093/eurheartj/ehae343
  33. Chaisirin W, Wongkrajang P, Thoesam T, Praphruetkit N, Nakornchai T, Riyapan S. Role of Point-of-Care Testing in Reducing Time to Treatment Decision-Making in Urgency Patients: A Randomized Controlled Trial. The Western Journal of Emergency Medicine. 2020; 21(2):404410. DOI: 10.5811/westjem.2019.10.43655
  34. Erasmus R, Sahni S, El-Sharkawy R. Connectivity Strategies in Managing a POCT Service. EJIFCC. 2021; 32(2):190194.
DOI: https://doi.org/10.5334/gh.1377 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jul 18, 2024
|
Accepted on: Nov 28, 2024
|
Published on: Dec 18, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Fabio Grunspun Pitta, Adriana Caschera Leme, Simone Rodrigues Gomes, Tarsila Perez Mota, Fernanda Vieira Paladino, José Leão de Souza Júnior, Rosemeire de Paula Braz, Thais Cristine Rodrigues Leonel Lamounier, Jéssica Buzin Gomes Ferreira, Carlos Eduardo dos Santos Ferreira, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.